Abstract
In severe status asthmaticus basic medical treatment often fails to improve the patient's condition. Mechanical ventilation in this situation is associated with a high incidence of serious complications. After the bronchodilating effect of moderate-dose magnesium sulfate in asthmatic patients had been demonstrated in previous studies we treated five mechanically ventilated patients with refractory status asthmaticus successfully with high dosages of MgSO4 IV (10–20 g within 1 h depending on the bronchodilating effect). MgSO4 resulted in a significant decrease of peak airway pressure (43.0±6.8 to 32.0±8.0 cmH2O) and inspiratory flow resistance (22.7±7.0 to 11.9±6.0 cmH2O·l−1·s−1) within 1 h. The resulting serum magnesium levels after one hour were up to threefold of the normal serum levels. Although a main-tainance dose of 0.4 g/h had been administered continuously during the following 24 h serum magnesium decreased towards normal values within this time. The only relevant side-effect was a mild to moderate arterial hypotension in two of the five patients during the high dose administration period of MgSO4 which responded readily to dopamine treatment.
Article PDF
Similar content being viewed by others
References
Mansel JK, Stogner SW, Petrini MF, Norman JR (1990) Mechanical ventilation in patients with acute severe asthma. Am J Med 89:42–48
Skobeloff EM, Spivey WH, McNamara RM, Greenspon L (1989) Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 262:1210–1213
Noppen M, Vanmaele L, Impens N, Schandevyl W (1990) Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma. Chest 97:373–376
Okayama H, Okayama M, Aikawa T, Sasaki H, Takishima T (1991) Treatment of status asthmaticus with intravenous magnesium sulfate. J Asthma 28:11–17
Sydow M, Burchardi H (1991) Intensive care management of lifethreatening status asthmaticus. In: Vincent JL (ed) Update in intensive care and emergency medicine, vol 14: Update 1991. Springer, Berlin Heidelberg New York Tokyo, pp 313–323
Mordes JP, Wacker WEC (1978) Excess magnesium. Pharmacol Rev 29:273–300
Crozier TA, Radke J, Weyland A, Sydow M, Seyde W, Markakis E, Kettler D (1991) Hemodynamic and endocrine effects of deliberate hypotension with magnesium sulfate for cerebral aneurysm surgery. Eur J Anaesthesiol 8:115–121
Lindeman KS, Hirshman CA, Freed AN (1989) Effect of magnesium sulfate on bronchoconstriction in the lung periphery. J Appl Physiol 66:2527–2532
Mordes JP, Swartz R, Arky RA (1975) Extreme hypermagnesemia as a cause of refractory hypotension. Ann Intern Med 83:657–658
Kufs WM (1990) Intravenous magnesium sulfate in acute asthma. JAMA 263:516–517
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sydow, M., Crozier, T.A., Zielmann, S. et al. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. Intensive Care Med 19, 467–471 (1993). https://doi.org/10.1007/BF01711089
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01711089